Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Sparks

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Thorax|October 1, 2021
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysisChristina Baggott, Jo Katherine Hardy, Jenny Sparks, et al.
Thorax|July 19, 2022
Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trialNethmi Kearns, Mathew Williams, Pepa Bruce, et al.
The European Respiratory Journal|May 24, 2020
Self-titration of inhaled corticosteroid and β<sub>2</sub>-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trialChristina Baggott, Jo Hardy, Jenny Sparks, et al.
Thorax|July 29, 2020
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experimentChristina Baggott, Paul Hansen, Robert J Hancox, et al.
Respirology (Carlton, Vic.)|March 12, 2025
Treatable Trait Guided Asthma Management: A Feasibility StudyJames Fingleton, Rob McLachlan, Jenny Sparks, et al.
The European Respiratory Journal|February 8, 2020
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trialChristina Baggott, Helen K Reddel, Jo Hardy, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
Lancet (London, England)|August 28, 2019
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialJo Hardy, Christina Baggott, James Fingleton, et al.
Clinical & Translational Immunology|April 4, 2018
A feasibility study: association between gut microbiota enterotype and antibody response to seasonal trivalent influenza vaccine in adultsNick Shortt, Hazel Poyntz, Wayne Young, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2022
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationHubert Chen, Rebecca Kunder, Yixuan Zou, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Thorax|October 1, 2021
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysisChristina Baggott, Jo Katherine Hardy, Jenny Sparks, et al.
Thorax|July 19, 2022
Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trialNethmi Kearns, Mathew Williams, Pepa Bruce, et al.
The European Respiratory Journal|May 24, 2020
Self-titration of inhaled corticosteroid and β<sub>2</sub>-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trialChristina Baggott, Jo Hardy, Jenny Sparks, et al.
Thorax|July 29, 2020
What matters most to patients when choosing treatment for mild-moderate asthma? Results from a discrete choice experimentChristina Baggott, Paul Hansen, Robert J Hancox, et al.
Respirology (Carlton, Vic.)|March 12, 2025
Treatable Trait Guided Asthma Management: A Feasibility StudyJames Fingleton, Rob McLachlan, Jenny Sparks, et al.
The European Respiratory Journal|February 8, 2020
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trialChristina Baggott, Helen K Reddel, Jo Hardy, et al.
Eclinicalmedicine|December 8, 2025
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trialPepa Bruce, Claire Houghton, Lee Hatter, et al.
Lancet (London, England)|August 28, 2019
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trialJo Hardy, Christina Baggott, James Fingleton, et al.
Clinical & Translational Immunology|April 4, 2018
A feasibility study: association between gut microbiota enterotype and antibody response to seasonal trivalent influenza vaccine in adultsNick Shortt, Hazel Poyntz, Wayne Young, et al.
Pulmonary Pharmacology & Therapeutics|June 1, 2022
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammationHubert Chen, Rebecca Kunder, Yixuan Zou, et al.
Pageof 2